Literature DB >> 1988764

Tourette syndrome and other tic disorders. Diagnosis, pathophysiology, and treatment.

H S Singer1, J T Walkup.   

Abstract

In this report, we discuss the definition, characteristics, pathophysiology, and treatment of tic disorders with a major emphasis on Tourette syndrome. Although the diagnosis of a tic disorder depends on the presence of motor and/or phonic tic(s), patients with these problems also have a variety of co-morbid features including obsessive-compulsive symptoms, attention-deficit hyperactivity disorder, behavioral difficulties, and learning disabilities. Conservative estimates for Tourette syndrome suggest a prevalence rate of 0.1-1.0 per 1000. This syndrome is inherited in a sex-influenced autosomal dominant pattern with either chronic multiple tic disorder or obsessive-compulsive disorder as alternative phenotypes of the putative gene. Current evidence continues to support a pathophysiologic mechanism involving synaptic neurotransmission, with the dopaminergic system as a primary candidate. Therapeutically, it is essential to clarify whether a patient's problems are related to tics or associated behavioral difficulties. Pharmacotherapy for motor and phonic tics is strictly symptomatic and should be reserved for those with functionally disabling symptoms. A comprehensive individualized treatment program is often required in the care of individuals with tic disorders.

Entities:  

Mesh:

Year:  1991        PMID: 1988764     DOI: 10.1097/00005792-199101000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  29 in total

Review 1.  Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: an overview.

Authors:  S Esposito; S Bianchini; E Baggi; M Fattizzo; D Rigante
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-24       Impact factor: 3.267

Review 2.  The biochemistry of Tourette's syndrome.

Authors:  P R Chokka; G B Baker; R A Bornstein; C M de Groot
Journal:  Metab Brain Dis       Date:  1995-06       Impact factor: 3.584

3.  Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance.

Authors:  J T Walkup; M C LaBuda; H S Singer; J Brown; M A Riddle; O Hurko
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

4.  PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome.

Authors:  N Turjanski; G V Sawle; E D Playford; R Weeks; A A Lammerstma; A J Lees; D J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

5.  Cocaine induced chronic tics.

Authors:  E Attig; R Amyot; T Botez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

Review 6.  The implication of neuroactive steroids in Tourette's syndrome pathogenesis: A role for 5α-reductase?

Authors:  M Bortolato; R Frau; S C Godar; L J Mosher; S Paba; F Marrosu; P Devoto
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

7.  Finasteride inhibited brain dopaminergic system and open-field behaviors in adolescent male rats.

Authors:  Li Li; Yun-Xiao Kang; Xiao-Ming Ji; Ying-Kun Li; Shuang-Cheng Li; Xiang-Jian Zhang; Hui-Xian Cui; Ge-Ming Shi
Journal:  CNS Neurosci Ther       Date:  2017-12-06       Impact factor: 5.243

8.  Advance information and movement sequencing in Gilles de la Tourette's syndrome.

Authors:  N Georgiou; J L Bradshaw; J G Phillips; J A Bradshaw; E Chiu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

Review 9.  Tourette's syndrome: are stimulants safe?

Authors:  Roger Kurlan
Journal:  Curr Neurol Neurosci Rep       Date:  2003-07       Impact factor: 5.081

10.  Association of genetic variations in X-ray repair cross-complementing group 1 and Tourette syndrome.

Authors:  Wei-Yong Lin; Cheng-Chun Lee; Hsin-Ping Liu; I-Ching Chou; Jim Jinn-Chyuan Sheu; Lei Wan; Ying-Ju Lin; Yuhsin Tsai; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2012-09       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.